LumiraDx’s HbA1c Test for Diabetes Gets CE Mark

LumiraDx’s blood test for diabetes that measures the level of hemoglobin (Hb) A1c — the amount of sugar attached to the glucose-hemoglobin part of the red blood cell — has received a CE mark.

The test, which runs on the LumiraDx Platform and provides results in under seven minutes at the point of care, shows how well the body has controlled the amount of sugar in the blood over the previous few months.

The HbA1c test is intended to monitor diabetes patients and as an aid in screening and identifying patients who may be at risk for developing diabetes.